The findings suggest that reconsideration of current clinical guidelines, which support MRI only for symptomatic brain ...
Metastatic breast cancer can come with many physical changes that can be noticeable and impact daily functioning, but there ...
The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with ...
Several studies show that isolation is very common among those diagnosed with metastatic breast cancer. However, there are ...
After living with metastatic breast cancer for 11 years, I reflect on my journey and plan to embrace the coming year with ...
BriaCell Therapeutics Corp. (BCTX, BCTXW) is down by 4.71 percent during Monday morning trading, following the announcement of a ...
BriaCell Therapeutics (TSX:BCT) is reporting that the first metastatic breast cancer patient treated with its Bria-OTS ...
During a Case-Based Roundtable event, Laura Huppert, MD, discussed data and considerations around using T-DXd in breast ...
DelveInsight’s, “Metastatic Breast Cancer Pipeline Insight” report provides comprehensive insights about 100+ companies and ...
The PATHWAY HER2 (4B5) test, the first and only FDA approved companion diagnostic for assessing HER2-low status since 2022, ...